2021 Tom Reeve Award

2021 Tom Reeve Award for Outstanding Contribution to Cancer Care

COSA is pleased to announce Professor Michael Barton OAM as the 2021 recipient of the Tom Reeve Award.

As one of his nominators said, “As a pioneer of academic radiation oncology in Australia, Michael has made, and is still making, outstanding contributions to clinical care, in oncological research, and cancer services policy throughout his career. He would be a very worthy recipient of the Tom Reeve Award.” And the COSA Board agrees.

Professor Barton will be well known to the COSA community. He is a clinical academic specialist Radiation Oncology at Liverpool Hospital, Cancer Therapy Centre and Research Director of the Collaboration for Cancer Outcomes Research and Evaluation (CCORE), who has dedicated his lifetime’s work to the improvement and innovation in the field of radiation oncology and cancer care.

Michael’s greatest contribution to radiation oncology in Australia and internationally may be considered his work in providing the evidence on which to base health policy and advising governments on frameworks for cancer services and then evaluating the impact of those services. A pivotal study was the determination from evidence-based treatment guidelines of the percentage of cancer patients who should receive radiation therapy at some time in their treatment, which enabled planning of radiation services.

Throughout his career he has mentored, educated and researched all the while providing excellent, team-based clinical care. This has provided an environment that has brought on another generation of researchers and provided clinical care in the more resource-challenged areas of Greater Sydney.

Michael initiated the Basic Science in Oncology Course (BSOC) which has continued to grow and thrive since its inception in the early 1990’s. Countless clinicians from a range of oncology and palliative care backgrounds have benefited from this work. Most recently, he brought together the three cancer streams through the Translational Cancer Research Centres (TCRC) at the University of New South Wales into a cohesive team working closely together on research and translation of research into clinical care.

Michael has written 42 commissioned reports for a wide variety of agencies on the delivery plans for various health jurisdictions, including the International Atomic Energy Agency (IAEA), the World Health Organisation (WHO), and the Global Taskforce for the use of Radiotherapy for Cancer Control (GTFRCC), an international collaboration to advise and plan for expansion of radiotherapy facilities around the world to better cater for the cancer needs of every country, especially those countries with serious health service delivery deficits. He chaired the Australian guidelines for the management of Adult Gliomas.

In terms of individual research output, as Research Director of CCORE he has been awarded over $20M in peer-reviewed funding. He has published 200 original scientific papers in peer-reviewed journals, 43 published abstracts, 9 editorials, 2 books, 15 book chapters, 8 electronic publications, and has over 9048 citation and an h-index of 46.

And the list goes on!

COSA encourages members to register for the 2021 ASM (if you haven’t already done so) where Professor Barton OAM will deliver his oration and be presented with the Tom Reeve Award, live streamed during the main program at 1:30pm on Wednesday 17 November.

More information about Professor Tom Reeve and the past award recipients is available here


Asia Pacific Journal of Clinical Oncology

Members have free online access.